Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold

Tissue Engineering - Part A

Volumn 15, Issue 8, 2009, Pages 1909-1918

  Tschoeke, Beate ^a   Flanagan, Thomas C ^a,e   Koch, Sabine ^a   Harwoko, Marvi Sri ^b   Deichmann, Thorsten ^b   Ellå, Ville ^c   Sachweh, Jörg S ^d   Kellomåki, Minna ^c   Gries, Thomas ^b   Schmitz Rode, Thomas ^a   Jockenhoevel, Stefan ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ABERRATIONS; BIOMECHANICS; BLOOD VESSEL PROSTHESES; CELL CULTURE; CELL MEMBRANES; ELECTRIC DISCHARGE MACHINING; ENDOTHELIAL CELLS; FIBROBLASTS; GRAFTING (CHEMICAL); MECHANICAL PROPERTIES; MUSCLE; SCAFFOLDS; SELF ASSEMBLY;

BIOABSORBABLE; BIODEGRADABLE COMPOSITES; BURST PRESSURES; CELL CARRIER; CELL NUMBER; CELL PHENOTYPE; CLINICAL APPLICATION; COLLAGEN CONTENT; CORONARY ARTERIES; CORONARY BYPASS; DYNAMIC MECHANICAL; ECM PROTEINS; EXTRACELLULAR MATRICES; GRAFT WALL; IN-VITRO; LACTIDES; MACROPOROUS; MECHANICAL STRENGTH; PATENCY RATES; PERIPHERAL ARTERIES; POLY LACTIDE; SCAFFOLD SYSTEM; SMOOTH MUSCLE CELLS; SYNTHETIC MATERIALS; VASCULAR GRAFTS;

GRAFTS;

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; FIBRIN; POLYLACTIDE; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BIOMECHANICS; BIOREACTOR; BLOOD VESSEL GRAFT; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEVICE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHEEP; SMOOTH MUSCLE FIBER; STAINING; STRENGTH; SURGICAL EQUIPMENT; TISSUE ENGINEERING; VASCULAR SURGERY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL ASSAY; BIOMECHANICS; BIOREACTORS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FIBRIN; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; POLYESTERS; POROSITY; SHEEP; STAINING AND LABELING; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 67649944061     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0499     Document Type: Article

References (43)

1. American Heart Association. Heart Disease and Stroke Statistics, 2006 Update. Dallas, TX: American Heart Association, 2006.
2. Kannan, R.Y., Salacinski, H.J., Butler, P.E., Hamilton, G., and Seifalian, A.M. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 74, 570, 2005.
3. Bergan, J.J., Veith, F.J., Bernhard, V.M., Yao, J.S., Flinn, W.R., Gupta, S.K., Scher, L.A., Samson, R.H., and Towne, J.B. Randomization of autogenous vein and polytetraflouroethylene grafts in femoral-distal reconstruction. Surgery 92, 921, 1982.
4. Sayers, R.D., Raptis, S., Berce, M., and Miller JH. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg 85, 934, 1998.
5. Greisler, H.P. Interactions at the blood/material interface. Ann Vasc Surg 4, 98, 1990.
6. Nerem, R.M., and Seliktar, D. Vascular tissue engineering. Annu Rev Biomed Eng 3, 225, 2001.
7. van der Giessen, W.J., Lincoff, A.M., Schwartz, R.S., van Beusekom, H.M., Serruys, P.W., Holmes, D.R., Jr., Ellis, S.G., and Topol, E.J. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94, 1690, 1996.
8. Athanasiou, K.A., Niederauer, G.G., and Agrawal, C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Bio-materials 17, 93, 1996.
9. Kasimir, M.T., Rieder, E., Seebacher, G., Wolner, E., Weigel, G., and Simon, P. Presence and elimination of the xenoantigen gal (alpha1, 3) in tissue-engineered heart valves. Tissue Eng 11, 1274, 2005.
10. L'Heureux, N., Paquet, S., Labbe, R., Germain, L., and Auger, F.A. A completely biological tissue-engineered human blood vessel. FASEB J 12, 47, 1998.
11. Weinberg, C.B., and Bell, E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231, 397, 1986.
12. Pool, J.G., Gershgold, E.J., and Pappenhagen, A.R. High potency anti-haemophilic factor prepared from cryoglobulin precipitate. Nature 203, 312, 1964.
13. Haisch, A., Loch, A., David, J., Pruss, A., Hansen, R., and Sittinger, M. Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med Biol Eng Comput 38, 686, 2000.
14. Ye, Q., Zund, G., Benedikt, P., Jockenhoevel, S., Hoerstrup, S.P., Sakyama, S., Hubbell, J.A., and Turina, M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17, 587, 2000.
15. Grassl, E.D., Oegema, T.R., and Tranquillo, R.T. Fibrin as an alternative biopolymer to type-I-collagen for the fabrication of a media equivalent. J Biomed Mater Res 60, 607, 2002.
16. Long, J.L., and Tranquillo, R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 22, 339, 2003.
17. Aper, T., Teebken, O.E., Steinhoff, G., and Haverich, A. Use of a fibrin preparation in the engineering of a vascular graft model. Eur J Vasc Endovasc Surg 28, 296, 2004.
18. Tschoeke, B., Flanagan, T.C., Cornelissen, A., Koch, S., Roehl, A., Sri Harwoko, M., Sachweh, J.S., Gries, T., Schmitz-Rode, T., and Jockenhoevel, S. Development of a composite degradable/non-degradable tissue-engineered vascular graft. Artif Organs 32, 800, 2008.
19. Flanagan, T.C., Black, A., O'Brien, M., Smith, T.J., and Pandit, A.S. Reference models for mitral valve tissue engineering based on valve cell phenotype and extracellular matrix analysis. Cells Tissues Organs 183, 12, 2006.
20. Dellenback, R.J., and Chien, S. The extinction coefficient of fibrinogen from man, dog, elephant, sheep, and goat at 280 mu. Proc Soc Exp Biol Med 134, 353, 1970.
21. Hata, R., and Senoo, H. L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissue-like substance by skin fibro-blasts. J Cell Physiol 138, 8, 1989.
22. Reddy, G.K., and Enwemeka, C.S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29, 225, 1996.
23. Miwa, H., Matsuda, T., and Iida, F. Development of a hierarchically structured hybrid vascular graft biomimicking natural arteries. ASAIO J 39, M273, 1993.
24. Ishibashi, K., and Matsuda, T. Reconstruction of a hybrid vascular graft hierarchically layered with three cell types. ASAIO J 40, M284, 1994.
25. Gundy, S., Gilcreest, V., Rochev, Y., Puolakka, A., Rissanen, M., Harwoko, M., Smith, T.J., and Barron, V. Human coronary artery smooth muscle cell response to a novel PLA textile/fibrin gel composite scaffold. Acta Biomater 4, 1734, 2008.
26. Seliktar, D., Black, R.A., Vito, R.P., and Nerem, R.M. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 28, 351, 2000.
27. Jackson, M.R. Fibrin sealants in surgical practice: an overview. Am J Surg 182, 1S, 2001.
28. Eppley, B.L., Pietrzak, W.S., and Blanton, M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 118, 147e, 2006.
29. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., and Langer, R. Functional arteries grown in vitro. Science 284, 489, 1999.
30. Xue, L., and Greisler, H.P. Biomaterials in the development and future of vascular grafts. J Vasc Surg 37, 472, 2003.
31. Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., and Shin'oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303, 2003.
32. Freed, L.E., Vunjak-Novakovic, G., Biron, R.J., Eagles, D.B., Lesnoy, D.C., Barlow, S.K., and Langer, R. Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) 12, 689, 1994.
33. Honkanen, P.B., Kellomäki, M., Lehtimäki, M.Y., Törmälä, P., Mäkelä, S., and Lehto, M.U. Bioreconstructive joint scaffold implant arthroplasty in metacarpophalangeal joints: short-term results of a new treatment concept in rheumatoid arthritis patients. Tissue Eng 9, 957, 2003.
34. Linnemann, B., Sri Harwoko, M., and Gries, T. Polylactide fibers (PLA). Chem Fibers Int 53, 426, 2003.
35. Shinoka, T., Shum-Tim, D., Ma, P.X., Tanel, R.E., Isogai, N., Langer, R., Vacanti, J.P., and Mayer, J.E., Jr. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115, 536, 1998.
36. Shum-Tim, D., Stock, U., Hrkach, J., Shinoka, T., Lien, J., Moses, M.A., Stamp, A., Taylor, G., Moran, A.M., Landis, W., Langer, R., Vacanti, J.P., and Mayer, J.E., Jr. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 68, 2298, 1999.
37. Ellä, V., Gomes, M.E., Reis, R.L., Törmälä, P., and Kellomäki, M. Studies of P(L/D)LA 96/4 non-woven scaffolds and fibres; properties, wettability and cell spreading before and after intrusive treatment methods. J Mater Sci Mater Med 18, 1253, 2007.
38. Jockenhoevel, S., Chalabi, K., Sachweh, J.S., Groesdonk, H.V., Demircan, L., Grossmann, M., Zund, G., and Messmer, B.J. Tissue engineering: complete autologous valve conduit - a new molding technique. Thorac Cardiovasc Surg 49, 287, 2001.
39. Flanagan, T.C., Cornelissen, C., Koch, S., Tschoeke, B., Sachweh, J.S., Schmitz-Rode, T., and Jockenhoevel, S. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28, 3388, 2007.
40. Patel, A., Fine, B., Sandig, M., and Mequanint, K. Elastin biosynthesis: the missing link in tissue-engineered blood vessels. Cardiovasc Res 71, 40, 2006.
41. Isenberg, B.C., Williams, C., and Tranquillo, R.T. Endothelialization and flow conditioning of fibrin-based media equivalents. Ann Biomed Eng 34, 971, 2006.
42. Hoerstrup, S.P., Zund, G., Sodian, R., Schnell, A.M., Grunenfelder, J., and Turina, M.I. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg 20, 164, 2001.
43. Grassl, E.D., Oegema, T.R., and Tranquillo, R.T. A fibrin-based media equivalent. J Biomed Mater Res A 66, 550, 2003.